Share Price and Basic Stock Data
Last Updated: November 22, 2025, 10:10 am
| PEG Ratio | 14.29 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
UTI Asset Management Company Ltd operates within the finance and mutual funds sector, with a current market capitalization of ₹14,774 Cr and a share price of ₹1,150. The company’s revenue trajectory has seen notable fluctuations, with sales reported at ₹1,267 Cr for the year ending March 2023, a decrease from ₹1,319 Cr in March 2022. However, a significant recovery is observed with sales projected to rise to ₹1,737 Cr in March 2024 and further to ₹1,851 Cr in March 2025, demonstrating a robust growth trend that reflects strong market demand and operational efficiency. Quarterly sales data indicates a recent surge, with ₹468 Cr recorded in June 2023, and continuing to ₹529 Cr by June 2024. This upward trend in sales underscores UTI’s effective management strategies and market positioning in the mutual fund industry.
Profitability and Efficiency Metrics
UTI Asset Management Company Ltd has reported commendable profitability metrics, with a net profit of ₹662 Cr for the trailing twelve months. The company’s operating profit margin (OPM) stood at an impressive 62%, indicating strong control over operating expenses relative to revenue. The profit before tax for March 2025 is projected at ₹1,052 Cr, up from ₹586 Cr in March 2023, signifying a substantial improvement in profitability. Furthermore, the return on equity (ROE) is reported at 16.3%, while the return on capital employed (ROCE) is at 21%, both of which are considered strong indicators of financial health compared to typical sector averages. Despite these strengths, the interest coverage ratio (ICR) is notably high at 87.37x, reflecting UTI’s robust ability to meet its interest obligations, further enhancing its financial stability.
Balance Sheet Strength and Financial Ratios
The balance sheet of UTI Asset Management Company Ltd reflects solid financial health, with no reported borrowings, which positions the company favorably in terms of financial leverage. The price-to-book value ratio (P/BV) stands at 2.93x, indicating that the market values the company at nearly three times its book value, a sign of investor confidence. The current ratio is exceptionally strong at 15.50, suggesting that the company is well-positioned to cover its short-term liabilities, which is significantly higher than typical industry benchmarks. Additionally, the cash conversion cycle is reported at 16 days, demonstrating efficient management of working capital. These metrics collectively highlight UTI’s resilience and ability to sustain growth without excessive debt, making it an attractive proposition for potential investors.
Shareholding Pattern and Investor Confidence
UTI’s shareholding pattern reveals a healthy distribution among institutional and public investors, with domestic institutional investors (DIIs) holding 59.71% of the shares, indicating strong institutional support. Foreign institutional investors (FIIs) have gradually increased their stake from 4.84% in June 2023 to 7.70% by June 2025, reflecting growing confidence in the company’s long-term prospects. The public shareholding stands at 32.68%, indicating a diversified investor base. The number of shareholders has slightly fluctuated, ending at 1,61,911, which shows a stable interest in UTI’s equity. This distribution suggests a solid foundation of investor confidence and a positive outlook towards UTI’s growth trajectory, aligning with the company’s strong financial performance and market position.
Outlook, Risks, and Final Insight
Looking ahead, UTI Asset Management Company Ltd is well-positioned for continued growth, driven by its robust profitability metrics and strong market demand for mutual funds. However, potential risks include market volatility and regulatory changes, which could impact investor sentiment and fund inflows. The company’s high dividend payout ratio, currently at 84%, may also limit its ability to reinvest profits for future growth. In a scenario of sustained market conditions, UTI is likely to continue on its growth trajectory, leveraging its strong financial position. Conversely, adverse market conditions or regulatory challenges could hinder its performance. In either case, UTI’s ongoing operational efficiency and strategic positioning will be crucial in navigating future challenges and opportunities.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of UTI Asset Management Company Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life AMC Ltd | 21,213 Cr. | 734 | 912/556 | 21.8 | 123 | 3.27 % | 35.5 % | 27.0 % | 5.00 |
| UTI Asset Management Company Ltd | 14,758 Cr. | 1,150 | 1,495/905 | 25.1 | 342 | 2.26 % | 21.0 % | 16.3 % | 10.0 |
| Nippon Life India Asset Management Ltd | 56,144 Cr. | 881 | 987/456 | 42.1 | 68.8 | 2.04 % | 40.7 % | 31.4 % | 10.0 |
| HDFC Asset Management Company Ltd | 1,15,531 Cr. | 5,394 | 5,934/3,525 | 42.1 | 362 | 0.83 % | 43.3 % | 32.4 % | 5.00 |
| Industry Average | 51,911.50 Cr | 2,039.75 | 32.78 | 223.95 | 2.10% | 35.13% | 26.78% | 7.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 293 | 435 | 295 | 301 | 468 | 404 | 449 | 416 | 529 | 538 | 418 | 376 | 547 |
| Expenses | 191 | 165 | 178 | 179 | 168 | 173 | 176 | 188 | 178 | 190 | 185 | 207 | 207 |
| Operating Profit | 103 | 270 | 117 | 122 | 300 | 232 | 273 | 228 | 351 | 348 | 233 | 169 | 340 |
| OPM % | 35% | 62% | 40% | 41% | 64% | 57% | 61% | 55% | 66% | 65% | 56% | 45% | 62% |
| Other Income | 13 | 4 | -2 | 8 | 1 | 2 | 1 | 4 | 5 | 2 | 3 | 0 | 2 |
| Interest | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 12 | 11 | 11 | 11 | 12 | 12 |
| Profit before tax | 104 | 262 | 103 | 117 | 288 | 220 | 261 | 218 | 341 | 336 | 221 | 154 | 326 |
| Tax % | 12% | 23% | 41% | 27% | 19% | 17% | 22% | 17% | 20% | 22% | 22% | 34% | 22% |
| Net Profit | 92 | 202 | 60 | 86 | 234 | 183 | 203 | 181 | 274 | 263 | 174 | 102 | 254 |
| EPS in Rs | 7.21 | 15.73 | 4.76 | 6.75 | 18.46 | 14.39 | 14.59 | 12.79 | 19.97 | 18.76 | 11.78 | 6.83 | 18.50 |
Last Updated: August 1, 2025, 9:40 am
Below is a detailed analysis of the quarterly data for UTI Asset Management Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 547.00 Cr.. The value appears strong and on an upward trend. It has increased from 376.00 Cr. (Mar 2025) to 547.00 Cr., marking an increase of 171.00 Cr..
- For Expenses, as of Jun 2025, the value is 207.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 207.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 340.00 Cr.. The value appears strong and on an upward trend. It has increased from 169.00 Cr. (Mar 2025) to 340.00 Cr., marking an increase of 171.00 Cr..
- For OPM %, as of Jun 2025, the value is 62.00%. The value appears strong and on an upward trend. It has increased from 45.00% (Mar 2025) to 62.00%, marking an increase of 17.00%.
- For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 326.00 Cr.. The value appears strong and on an upward trend. It has increased from 154.00 Cr. (Mar 2025) to 326.00 Cr., marking an increase of 172.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 34.00% (Mar 2025) to 22.00%, marking a decrease of 12.00%.
- For Net Profit, as of Jun 2025, the value is 254.00 Cr.. The value appears strong and on an upward trend. It has increased from 102.00 Cr. (Mar 2025) to 254.00 Cr., marking an increase of 152.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 18.50. The value appears strong and on an upward trend. It has increased from 6.83 (Mar 2025) to 18.50, marking an increase of 11.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:12 am
| Metric | Mar 2008 | Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 442 | 497 | 502 | 934 | 1,134 | 1,051 | 854 | 1,169 | 1,319 | 1,267 | 1,737 | 1,851 | 1,759 |
| Expenses | 219 | 292 | 298 | 499 | 577 | 552 | 506 | 526 | 621 | 655 | 703 | 749 | 840 |
| Operating Profit | 223 | 206 | 204 | 435 | 558 | 498 | 349 | 643 | 698 | 612 | 1,034 | 1,102 | 919 |
| OPM % | 50% | 41% | 41% | 47% | 49% | 47% | 41% | 55% | 53% | 48% | 60% | 60% | 52% |
| Other Income | 4 | 2 | 1 | 13 | 22 | 30 | 36 | 4 | 8 | 23 | 6 | 9 | 7 |
| Interest | 0 | 0 | 0 | 0 | 0 | 8 | 9 | 8 | 9 | 10 | 11 | 13 | 13 |
| Depreciation | 6 | 9 | 10 | 13 | 14 | 29 | 34 | 36 | 37 | 40 | 42 | 46 | 48 |
| Profit before tax | 221 | 199 | 195 | 435 | 566 | 491 | 341 | 603 | 660 | 586 | 987 | 1,052 | 865 |
| Tax % | 32% | 30% | 25% | 26% | 29% | 29% | 19% | 18% | 19% | 25% | 19% | 23% | |
| Net Profit | 151 | 139 | 147 | 321 | 402 | 348 | 275 | 494 | 535 | 440 | 802 | 813 | 662 |
| EPS in Rs | 12.12 | 11.12 | 11.73 | 25.29 | 31.68 | 27.83 | 21.41 | 38.97 | 42.09 | 34.44 | 60.17 | 57.16 | 45.92 |
| Dividend Payout % | 26% | 25% | 23% | 16% | 16% | 18% | 33% | 44% | 50% | 64% | 78% | 84% |
YoY Net Profit Growth
| Year | 2011-2012 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 5.76% | 25.23% | -13.43% | -20.98% | 79.64% | 8.30% | -17.76% | 82.27% | 1.37% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.48% | -38.67% | -7.54% | 100.61% | -71.34% | -26.06% | 100.03% | -80.90% |
UTI Asset Management Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2011-2012 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 12% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 11% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 17% |
| 1 Year: | 6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:50 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2008 | Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2008 | Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 7 | 5 | 18 | 3 | 9 | 10 | 19 | 14 | 22 | 27 | 18 | 16 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 7 | 5 | 18 | 3 | 9 | 10 | 19 | 14 | 22 | 27 | 18 | 16 |
| Working Capital Days | -26 | -62 | -44 | -28 | -40 | -31 | -24 | -47 | -31 | -32 | -33 | -51 |
| ROCE % | 42% | 21% | 27% | 20% | 13% | 20% | 19% | 16% | 23% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Parag Parikh Flexi Cap Fund | 2,726,649 | 0.38 | 272.8 | 2,726,649 | 2025-04-22 17:25:16 | 0% |
| Nippon India Small Cap Fund | 2,267,244 | 0.4 | 226.84 | 2,267,244 | 2025-04-22 17:25:16 | 0% |
| Nippon India Multi Cap Fund | 2,166,707 | 0.62 | 216.78 | 2,166,707 | 2025-04-22 15:56:52 | 0% |
| Tata Equity P/E Fund - Regular Plan | 2,053,547 | 2.42 | 205.46 | 2,053,547 | 2025-04-22 17:25:16 | 0% |
| Tata Equity P/E Fund - Regular Plan - Trigger Option A 5% | 2,053,547 | 2.42 | 205.46 | 2,053,547 | 2025-04-22 11:25:17 | 0% |
| Tata Small Cap Fund | 1,965,500 | 2.5 | 196.65 | 1,965,500 | 2025-04-22 17:25:16 | 0% |
| Nippon India ELSS Tax Saver Fund | 1,302,681 | 0.82 | 130.33 | 1,302,681 | 2025-04-22 15:56:52 | 0% |
| Nippon India Banking & Financial Services Fund | 1,141,962 | 1.93 | 114.25 | 1,141,962 | 2025-04-22 15:56:52 | 0% |
| Nippon India Value Fund | 788,543 | 0.96 | 78.89 | 788,543 | 2025-04-22 17:25:16 | 0% |
| Tata ELSS Tax Saver Fund | 505,000 | 1.11 | 50.53 | 505,000 | 2025-04-22 15:56:52 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 57.35 | 60.26 | 34.45 | 42.12 | 38.97 |
| Diluted EPS (Rs.) | 57.11 | 60.22 | 34.44 | 41.96 | 38.97 |
| Cash EPS (Rs.) | 67.08 | 66.34 | 37.77 | 45.01 | 41.81 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 359.36 | 390.79 | 304.60 | 284.97 | 257.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 359.36 | 390.79 | 304.60 | 284.97 | 257.36 |
| Revenue From Operations / Share (Rs.) | 144.64 | 136.49 | 99.77 | 103.91 | 92.16 |
| PBDIT / Share (Rs.) | 86.77 | 81.75 | 50.02 | 55.63 | 51.02 |
| PBIT / Share (Rs.) | 83.21 | 78.43 | 46.87 | 52.73 | 48.20 |
| PBT / Share (Rs.) | 82.21 | 77.55 | 46.12 | 52.00 | 47.56 |
| Net Profit / Share (Rs.) | 63.52 | 63.02 | 34.63 | 42.11 | 38.99 |
| NP After MI And SOA / Share (Rs.) | 57.16 | 60.17 | 34.44 | 42.09 | 38.97 |
| PBDIT Margin (%) | 59.98 | 59.89 | 50.13 | 53.53 | 55.35 |
| PBIT Margin (%) | 57.52 | 57.46 | 46.97 | 50.74 | 52.29 |
| PBT Margin (%) | 56.84 | 56.81 | 46.22 | 50.04 | 51.60 |
| Net Profit Margin (%) | 43.91 | 46.17 | 34.70 | 40.52 | 42.30 |
| NP After MI And SOA Margin (%) | 39.51 | 44.08 | 34.52 | 40.50 | 42.28 |
| Return on Networth / Equity (%) | 15.90 | 17.44 | 11.30 | 14.81 | 15.19 |
| Return on Capital Employeed (%) | 19.99 | 19.69 | 15.17 | 18.10 | 18.05 |
| Return On Assets (%) | 12.92 | 14.33 | 10.47 | 13.39 | 13.53 |
| Asset Turnover Ratio (%) | 0.33 | 0.36 | 0.28 | 0.29 | 0.29 |
| Current Ratio (X) | 15.50 | 17.83 | 14.66 | 12.25 | 12.12 |
| Quick Ratio (X) | 15.50 | 17.83 | 14.66 | 12.25 | 12.12 |
| Dividend Payout Ratio (NP) (%) | 81.84 | 36.48 | 60.96 | 40.34 | 17.96 |
| Dividend Payout Ratio (CP) (%) | 77.04 | 34.57 | 55.86 | 37.74 | 16.74 |
| Earning Retention Ratio (%) | 18.16 | 63.52 | 39.04 | 59.66 | 82.04 |
| Cash Earning Retention Ratio (%) | 22.96 | 65.43 | 44.14 | 62.26 | 83.26 |
| Interest Coverage Ratio (X) | 87.37 | 92.31 | 66.50 | 76.93 | 80.26 |
| Interest Coverage Ratio (Post Tax) (X) | 64.96 | 72.17 | 47.04 | 59.23 | 62.33 |
| Enterprise Value (Cr.) | 13539.42 | 10626.57 | 7783.48 | 12236.34 | 7066.17 |
| EV / Net Operating Revenue (X) | 7.31 | 6.12 | 6.14 | 9.28 | 6.05 |
| EV / EBITDA (X) | 12.19 | 10.21 | 12.26 | 17.33 | 10.92 |
| MarketCap / Net Operating Revenue (X) | 7.28 | 5.97 | 6.43 | 9.57 | 6.32 |
| Retention Ratios (%) | 18.15 | 63.51 | 39.03 | 59.65 | 82.03 |
| Price / BV (X) | 2.93 | 2.36 | 2.10 | 3.50 | 2.27 |
| Price / Net Operating Revenue (X) | 7.28 | 5.97 | 6.43 | 9.57 | 6.32 |
| EarningsYield | 0.05 | 0.07 | 0.05 | 0.04 | 0.06 |
After reviewing the key financial ratios for UTI Asset Management Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 57.35. This value is within the healthy range. It has decreased from 60.26 (Mar 24) to 57.35, marking a decrease of 2.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is 57.11. This value is within the healthy range. It has decreased from 60.22 (Mar 24) to 57.11, marking a decrease of 3.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 67.08. This value is within the healthy range. It has increased from 66.34 (Mar 24) to 67.08, marking an increase of 0.74.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 359.36. It has decreased from 390.79 (Mar 24) to 359.36, marking a decrease of 31.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 359.36. It has decreased from 390.79 (Mar 24) to 359.36, marking a decrease of 31.43.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 144.64. It has increased from 136.49 (Mar 24) to 144.64, marking an increase of 8.15.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 86.77. This value is within the healthy range. It has increased from 81.75 (Mar 24) to 86.77, marking an increase of 5.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 83.21. This value is within the healthy range. It has increased from 78.43 (Mar 24) to 83.21, marking an increase of 4.78.
- For PBT / Share (Rs.), as of Mar 25, the value is 82.21. This value is within the healthy range. It has increased from 77.55 (Mar 24) to 82.21, marking an increase of 4.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 63.52. This value is within the healthy range. It has increased from 63.02 (Mar 24) to 63.52, marking an increase of 0.50.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 57.16. This value is within the healthy range. It has decreased from 60.17 (Mar 24) to 57.16, marking a decrease of 3.01.
- For PBDIT Margin (%), as of Mar 25, the value is 59.98. This value is within the healthy range. It has increased from 59.89 (Mar 24) to 59.98, marking an increase of 0.09.
- For PBIT Margin (%), as of Mar 25, the value is 57.52. This value exceeds the healthy maximum of 20. It has increased from 57.46 (Mar 24) to 57.52, marking an increase of 0.06.
- For PBT Margin (%), as of Mar 25, the value is 56.84. This value is within the healthy range. It has increased from 56.81 (Mar 24) to 56.84, marking an increase of 0.03.
- For Net Profit Margin (%), as of Mar 25, the value is 43.91. This value exceeds the healthy maximum of 10. It has decreased from 46.17 (Mar 24) to 43.91, marking a decrease of 2.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 39.51. This value exceeds the healthy maximum of 20. It has decreased from 44.08 (Mar 24) to 39.51, marking a decrease of 4.57.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.90. This value is within the healthy range. It has decreased from 17.44 (Mar 24) to 15.90, marking a decrease of 1.54.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.99. This value is within the healthy range. It has increased from 19.69 (Mar 24) to 19.99, marking an increase of 0.30.
- For Return On Assets (%), as of Mar 25, the value is 12.92. This value is within the healthy range. It has decreased from 14.33 (Mar 24) to 12.92, marking a decrease of 1.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has decreased from 0.36 (Mar 24) to 0.33, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 15.50. This value exceeds the healthy maximum of 3. It has decreased from 17.83 (Mar 24) to 15.50, marking a decrease of 2.33.
- For Quick Ratio (X), as of Mar 25, the value is 15.50. This value exceeds the healthy maximum of 2. It has decreased from 17.83 (Mar 24) to 15.50, marking a decrease of 2.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 81.84. This value exceeds the healthy maximum of 50. It has increased from 36.48 (Mar 24) to 81.84, marking an increase of 45.36.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 77.04. This value exceeds the healthy maximum of 50. It has increased from 34.57 (Mar 24) to 77.04, marking an increase of 42.47.
- For Earning Retention Ratio (%), as of Mar 25, the value is 18.16. This value is below the healthy minimum of 40. It has decreased from 63.52 (Mar 24) to 18.16, marking a decrease of 45.36.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 22.96. This value is below the healthy minimum of 40. It has decreased from 65.43 (Mar 24) to 22.96, marking a decrease of 42.47.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 87.37. This value is within the healthy range. It has decreased from 92.31 (Mar 24) to 87.37, marking a decrease of 4.94.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 64.96. This value is within the healthy range. It has decreased from 72.17 (Mar 24) to 64.96, marking a decrease of 7.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 13,539.42. It has increased from 10,626.57 (Mar 24) to 13,539.42, marking an increase of 2,912.85.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.31. This value exceeds the healthy maximum of 3. It has increased from 6.12 (Mar 24) to 7.31, marking an increase of 1.19.
- For EV / EBITDA (X), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 10.21 (Mar 24) to 12.19, marking an increase of 1.98.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.28. This value exceeds the healthy maximum of 3. It has increased from 5.97 (Mar 24) to 7.28, marking an increase of 1.31.
- For Retention Ratios (%), as of Mar 25, the value is 18.15. This value is below the healthy minimum of 30. It has decreased from 63.51 (Mar 24) to 18.15, marking a decrease of 45.36.
- For Price / BV (X), as of Mar 25, the value is 2.93. This value is within the healthy range. It has increased from 2.36 (Mar 24) to 2.93, marking an increase of 0.57.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.28. This value exceeds the healthy maximum of 3. It has increased from 5.97 (Mar 24) to 7.28, marking an increase of 1.31.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.05, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UTI Asset Management Company Ltd:
- Net Profit Margin: 43.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.99% (Industry Average ROCE: 35.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.9% (Industry Average ROE: 26.78%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 64.96
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 15.5
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.1 (Industry average Stock P/E: 32.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 43.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance - Mutual Funds | UTI Tower, G N Block, Mumbai Maharashtra 400051 | cs@uti.co.in https://www.utimf.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dinesh Kumar Mehrotra | Non Exe.Chairman&Ind.Director |
| Mr. Imtaiyazur Rahman | Managing Director & CEO |
| Mr. Flemming Madsen | Non Exe. & Nominee Director |
| Mr. Srivatsa Desikamani | Non Exe. & Nominee Director |
| Mr. Santosh Kumar | Non Exe. & Nominee Director |
| Mr. Narasimhan Seshadri | Ind. Non-Executive Director |
| Mr. Deepak Kumar Chatterjee | Ind. Non-Executive Director |
| Ms. Jayashree Vaidhyanathan | Ind. Non-Executive Director |